CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹27,548 Cr | ₹25,774 Cr | ₹22,753 Cr | ₹21,763 Cr | ₹19,160 Cr |
What is the latest Revenue of CIPLA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹27,548 Cr |
| Mar2025 | ₹25,774 Cr |
| Mar2024 | ₹22,753 Cr |
| Mar2023 | ₹21,763 Cr |
| Mar2022 | ₹19,160 Cr |
How is Revenue of CIPLA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹27,548 Cr | 6.88 | |
| Mar2025 | ₹25,774 Cr | 13.28 | |
| Mar2024 | ₹22,753 Cr | 4.55 | |
| Mar2023 | ₹21,763 Cr | 13.59 | |
| Mar2022 | ₹19,160 Cr | - | |
Compare Revenue of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹115,933.7 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
| MANKIND PHARMA | ₹98,086.5 Cr | -0.6% | -5.2% | -4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.2% |
1.7% |
-8.8% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses